Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Cell Biology

Background:

• Tissue ischemia, often resulting from myocardial infarction or peripheral arterial disease, presents significant clinical challenges.
• Stem cell therapy offers a potential regenerative approach to address tissue damage and dysfunction caused by ischemia.
• Existing research highlights the therapeutic benefits of various stem and progenitor cells in preclinical and clinical settings.

Purpose of the Study:

• To provide a comprehensive overview of stem cell therapy for ischemic conditions.
• To summarize the current applications of different stem cell types in treating myocardial infarction and peripheral arterial disease.
• To review the state-of-the-art in stem cell-based regenerative medicine for cardiovascular and peripheral vascular diseases.

Main Methods:

• Literature review of preclinical and clinical studies on stem cell therapy for tissue ischemia.
• Categorization of stem and progenitor cells, including pluripotent stem cells, adult stem cells, and their subtypes.
• Analysis of therapeutic benefits, focusing on angiogenesis and tissue function restoration.

Main Results:

• Stem and progenitor cells, derived from bone marrow or pluripotent sources, demonstrate therapeutic potential.
• Adult stem cells, such as mononuclear cells, endothelial progenitor cells, and mesenchymal stem cells, have advanced to clinical trials.
• Positive benefits have been observed in clinical trials, indicating efficacy in improving tissue perfusion and function.

Conclusions:

• Stem cell therapy is a viable and promising strategy for managing tissue ischemia in myocardial infarction and peripheral arterial disease.
• The reviewed stem cell types, particularly adult stem cells, exhibit significant potential for promoting angiogenesis and functional recovery.
• Continued research and clinical translation of stem cell therapies are crucial for advancing treatment options for ischemic diseases.